|
THAP5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.155000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.946100E-02 |
| Normal-vs-Stage2 |
3.125600E-01 |
| Normal-vs-Stage3 |
3.88659999994712E-06 |
| Normal-vs-Stage4 |
6.32950000190036E-08 |
| Stage1-vs-Stage2 |
9.998600E-01 |
| Stage1-vs-Stage3 |
5.680400E-03 |
| Stage1-vs-Stage4 |
2.043600E-04 |
| Stage2-vs-Stage3 |
1.569770E-01 |
| Stage2-vs-Stage4 |
8.633800E-02 |
| Stage3-vs-Stage4 |
6.061000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.409300E-04 |
| Normal-vs-AfricanAmerican |
4.30650000105004E-08 |
| Normal-vs-Asian |
4.635900E-02 |
| Caucasian-vs-AfricanAmerican |
1.497950E-03 |
| Caucasian-vs-Asian |
6.850000E-01 |
| AfricanAmerican-vs-Asian |
4.925800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.3294000000027E-05 |
| Normal-vs-Female |
1.268380E-02 |
| Male-vs-Female |
3.028000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.025000E-04 |
| Normal-vs-Age(41-60Yrs) |
9.577200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.035170E-04 |
| Normal-vs-Age(81-100Yrs) |
1.798330E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.007770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.767800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.060000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.179000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.203600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.542000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.807400E-01 |
| Normal-vs-Grade 2 |
2.625600E-01 |
| Normal-vs-Grade 3 |
1.14979999998877E-06 |
| Normal-vs-Grade 4 |
2.13560280570846E-11 |
| Grade 1-vs-Grade 2 |
7.258000E-01 |
| Grade 1-vs-Grade 3 |
1.903030E-01 |
| Grade 1-vs-Grade 4 |
5.435500E-03 |
| Grade 2-vs-Grade 3 |
7.648300E-04 |
| Grade 2-vs-Grade 4 |
5.10559999833404E-08 |
| Grade 3-vs-Grade 4 |
2.803200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.625200E-01 |
| Normal-vs-ccB subtype |
2.17950000047651E-07 |
| ccA subtype-vs-ccB subtype |
3.23590000017582E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.841500E-03 |
| Normal-vs-N1 |
4.955400E-04 |
| N0-vs-N1 |
1.978360E-01 |
|
|
